+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neuropathic Pain Drug Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4968619
  • Report
  • January 2020
  • Region: Global
  • 113 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Biogen Idec Inc.
  • Depomed Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
The Global Neuropathic Pain Drug Market is expected to grow from USD 7,598.48 Million in 2018 to USD 13,938.27 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.05%.

The positioning of the Global Neuropathic Pain Drug Market vendors in the FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report exploresthe recent significant developments by the leading vendors and innovation profiles in the Global Neuropathic Pain Drug Market including are Bristol-Myers Squibb and Company, Eli Lily and Company, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Pfizer Inc., Baxter Healthcare Corporation, Biogen Idec Inc., Depomed Inc., and Sanofi S.A..

On the basis of Type, the Global Neuropathic Pain Drug Market is examined across Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy, and Trigeminal Neuralgia.

On the basis of Treatment, the Global Neuropathic Pain Drug Market is examined across Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type.

On the basis of Indication, the Global Neuropathic Pain Drug Market is examined across Diabetic Neuropathy and Spinal Stenosis.

On the basis of Diagnosis, the Global Neuropathic Pain Drug Market is examined across Blood Tests and Imaging Physical Examination.

On the basis of Distribution, the Global Neuropathic Pain Drug Market is examined across Online Pharmacies and Retail Pharmacies & Drug Stores.

On the basis of End User, the Global Neuropathic Pain Drug Market is examined across Clinics and Hospitals.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Neuropathic Pain Drug Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Neuropathic Pain Drug Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Neuropathic Pain Drug Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Neuropathic Pain Drug Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Neuropathic Pain Drug Market

The report answers questions such as:

1. What is the market size of the global Neuropathic Pain Drug market?
2. What are the factors that affect the growth in the Global Neuropathic Pain Drug Market over the forecast period?
3. What is the competitive position in the Global Neuropathic Pain Drug Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Neuropathic Pain Drug Market?
5. What are the opportunities in the Global Neuropathic Pain Drug Market?
6. What are the modes of entering the Global Neuropathic Pain Drug Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biogen Idec Inc.
  • Depomed Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Neuropathic Pain Drug Market
3.2. Opportunities in the Neuropathic Pain Drug Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Neuropathic Pain Drug Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Phantom Limb Pain
5.4. Post Herpetic Neuralgia
5.5. Post-traumatic Neuropathy
5.6. Trigeminal Neuralgia

6. Global Neuropathic Pain Drug Market, by Treatment
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Antidepressant Drugs Type
6.3.1. Serotonin Noradrenaline
6.3.2. Tricyclic Antidepressants
6.4. Medication Type
6.5. Multimodal Therapy
6.6. NSAIDs Type
6.6.1. Ibuprofen
6.6.2. Naproxen

7. Global Neuropathic Pain Drug Market, by Indication
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Diabetic Neuropathy
7.4. Spinal Stenosis

8. Global Neuropathic Pain Drug Market, by Diagnosis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Blood Tests
8.4. Imaging Physical Examination
8.4.1. CT
8.4.2. Electromyography
8.4.3. MRI

9. Global Neuropathic Pain Drug Market, by Distribution
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Online Pharmacies
9.4. Retail Pharmacies & Drug Stores

10. Global Neuropathic Pain Drug Market, by End User
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. Clinics
10.4. Hospitals

11. Global Neuropathic Pain Drug Market, by Geography
11.1. Overview
11.2. Market Sizing & Forecasting
11.3. Americas
11.3.1. Overview
11.3.2. Market Sizing & Forecasting
11.3.3. Argentina
11.3.4. Brazil
11.3.5. Canada
11.3.6. Mexico
11.3.7. United States
11.4. Asia-Pacific
11.4.1. Overview
11.4.2. Market Sizing & Forecasting
11.4.3. Australia
11.4.4. China
11.4.5. India
11.4.6. Japan
11.5. Europe, Middle East & Africa
11.5.1. Overview
11.5.2. Market Sizing & Forecasting
11.5.3. France
11.5.4. Germany
11.5.5. Italy
11.5.6. Spain
11.5.7. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix for Global Neuropathic Pain Drug Market
12.2. Market Vendor Ranking Analysis for Global Neuropathic Pain Drug Market
12.3. Competitive News Feed Analysis for Global Neuropathic Pain Drug Market

13. Company Usability Profiles
13.1. Bristol-Myers Squibb and Company
13.1.1. Overview
13.1.2. Strategy
13.1.3. SWOT
13.2. Eli Lily and Company
13.2.1. Overview
13.2.2. Strategy
13.2.3. SWOT
13.3. GlaxoSmithKline PLC
13.3.1. Overview
13.3.2. Strategy
13.3.3. SWOT
13.4. Johnson & Johnson Services Inc.
13.4.1. Overview
13.4.2. Strategy
13.4.3. SWOT
13.5. Pfizer Inc.
13.5.1. Overview
13.5.2. Strategy
13.5.3. SWOT
13.6. Baxter Healthcare Corporation
13.7. Biogen Idec Inc.
13.8. Depomed Inc.
13.9. Sanofi S.A.

14. Appendix
14.1. Discussion Guide
14.2. Top Reports
14.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
14.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
14.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
14.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
14.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
14.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bristol-Myers Squibb and Company
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Baxter Healthcare Corporation
  • Biogen Idec Inc.
  • Depomed Inc.
  • Sanofi S.A.
Note: Product cover images may vary from those shown
Adroll
adroll